This site is intended for healthcare professionals only

New Use of NOACs in a patient who requires an AF ablation

With

Dr Hugh Calkins

Approx. time required 30 mins
Watch now

New Management of anticoagulation for a patient undergoing percutaneous cardiac intervention (PCI)

With

Professor Christoph Bode

Approx. time required 30 mins
Watch now

New NOAC dosage for patients undergoing cardioversion for atrial fibrillation

With

Dr Michael Ezekowitz

Approx. time required 30 mins
Watch now

New Publication Update: Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors

With

Dr Stuart Connolly

Approx. time required 30 mins
Watch Now

Therapy with non-vitamin K oral anticoagulants (NOACs) gives us with the best opportunity that we have had to increase anticoagulation for patient with at-risk atrial fibrillation and greatly reduce stroke burden that complicates this arrhythmia.

Professor John Camm, NOAC Faculty member